Pages
(Move to ...)
Home
Northwell Nephrology Fellowship
The Galdi Fellowship(GN-Onconephrology)
Concept Maps
Detective Nephron Series(ASN Kidney News)
Teaching Resources
Journals
Society Links
Cases/Quiz
Crosswords
GN Chat
Anagrams
GNin10 Podcasts( ISGD)
About
▼
Take a look here
(Move to ...)
Home
About
Journals
Non renal Blogs of interest
Society Links
Teaching Resources
Crosswords
Anagrams
Cases/Quiz
Board Preparation
Neph JC
Nephrology Fellowship
Concept Maps
Detective Nephron Series(ASN Kidney News)
▼
Friday, August 30, 2013
In the NEWS: mTOR inhibitors and ATN
›
MTOR inhibitors are widely used in many GU cancers and in kidney transplantations. mTOR inhibitors are known to cause proteinuria and many c...
Thursday, August 29, 2013
TOPIC DISCUSSION: Risk factors for UTI in Transplant patients
›
What are independent risk factors for early urinary tract infections in renal transplants? 1. Female Gender 2. Prolonged use of foley 3....
Wednesday, August 28, 2013
Dr. House, Sherlock Holmes and Medical Education
›
Medical TV shows such as Dr. House and detective books such as of Watson and Holmes have now entered medical education literature to deduce ...
Sunday, August 18, 2013
Message from the NRAA regarding a medical director workshop meeting in Fall 2013.
›
NRAA Announces Physician Panel for Medical Director Workshop & Nephrology Symposium NRAA, introduces the physician-led panel for th...
Friday, August 16, 2013
Frail Renal Phenotype
›
Frailty in the elderly or any patient leading towards ESRD is a tough combination. Renal physicians should not consider dialysis as the de f...
Thursday, August 15, 2013
Coffee, tea, or soda: are they going to cause kidney stones?
›
Beverages and risk of kidney stones has been a recently studied topic . Recently published studies and most recent being in CJASN by ...
Tuesday, August 13, 2013
Consult Rounds: Psoriasis and kidney disease
›
Psoriasis is an immune-mediated chronic inflammatory disorder of the skin. Association with kidney disease has been debated for a long time...
3 comments:
‹
›
Home
View web version